These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27009491)

  • 1. HIV Protease Inhibitor-Induced Cathepsin Modulation Alters Antigen Processing and Cross-Presentation.
    Kourjian G; Rucevic M; Berberich MJ; Dinter J; Wambua D; Boucau J; Le Gall S
    J Immunol; 2016 May; 196(9):3595-607. PubMed ID: 27009491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.
    Boucau J; Madouasse J; Kourjian G; Carlin CS; Wambua D; Berberich MJ; Le Gall S
    J Immunol; 2019 May; 202(10):2856-2872. PubMed ID: 30936293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.
    Frey BF; Jiang J; Sui Y; Boyd LF; Yu B; Tatsuno G; Billeskov R; Solaymani-Mohammadi S; Berman PW; Margulies DH; Berzofsky JA
    J Immunol; 2018 Mar; 200(5):1853-1864. PubMed ID: 29374075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis.
    Hari A; Ganguly A; Mu L; Davis SP; Stenner MD; Lam R; Munro F; Namet I; Alghamdi E; Fürstenhaupt T; Dong W; Detampel P; Shen LJ; Amrein MW; Yates RM; Shi Y
    Eur J Immunol; 2015 Feb; 45(2):383-95. PubMed ID: 25378230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence-specific alterations of epitope production by HIV protease inhibitors.
    Kourjian G; Xu Y; Mondesire-Crump I; Shimada M; Gourdain P; Le Gall S
    J Immunol; 2014 Apr; 192(8):3496-506. PubMed ID: 24616479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing.
    Allan ER; Tailor P; Balce DR; Pirzadeh P; McKenna NT; Renaux B; Warren AL; Jirik FR; Yates RM
    J Immunol; 2014 Jun; 192(11):4989-5001. PubMed ID: 24778444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid peroxidation causes endosomal antigen release for cross-presentation.
    Dingjan I; Verboogen DR; Paardekooper LM; Revelo NH; Sittig SP; Visser LJ; Mollard GF; Henriet SS; Figdor CG; Ter Beest M; van den Bogaart G
    Sci Rep; 2016 Feb; 6():22064. PubMed ID: 26907999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL.
    Choi SH; Gonen A; Diehl CJ; Kim J; Almazan F; Witztum JL; Miller YI
    Autophagy; 2015; 11(5):785-95. PubMed ID: 25946330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.
    Rucevic M; Kourjian G; Boucau J; Blatnik R; Garcia Bertran W; Berberich MJ; Walker BD; Riemer AB; Le Gall S
    J Virol; 2016 Oct; 90(19):8605-20. PubMed ID: 27440904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition.
    Dinter J; Gourdain P; Lai NY; Duong E; Bracho-Sanchez E; Rucevic M; Liebesny PH; Xu Y; Shimada M; Ghebremichael M; Kavanagh DG; Le Gall S
    J Immunol; 2014 Nov; 193(9):4322-4334. PubMed ID: 25230751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection.
    Pires D; Valente S; Calado M; Mandal M; Azevedo-Pereira JM; Anes E
    Front Immunol; 2021; 12():647728. PubMed ID: 33841429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells.
    Reich M; Lesner A; Legowska A; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
    Mol Immunol; 2009 Sep; 46(15):2994-9. PubMed ID: 19615749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.
    Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V
    J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
    Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
    J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct antigen uptake receptors route to the same storage compartments for cross-presentation in dendritic cells.
    Ho NI; Camps MG; Garcia-Vallejo JJ; Bos E; Koster AJ; Verdoes M; van Kooyk Y; Ossendorp F
    Immunology; 2021 Nov; 164(3):494-506. PubMed ID: 34110622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells.
    Boucau J; Das J; Joshi N; Le Gall S
    PLoS Pathog; 2020 Mar; 16(3):e1008442. PubMed ID: 32196533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection.
    Mwangi W; Brown WC; Splitter GA; Zhuang Y; Kegerreis K; Palmer GH
    J Leukoc Biol; 2005 Aug; 78(2):401-11. PubMed ID: 15857936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.